ACCME Accreditation Statement:
The Medical College of Wisconsin is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
AMA Credit Designation Statement:
The Medical College of Wisconsin designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Hours of Participation for Allied Health Care Professionals:
The Medical College of Wisconsin designates this activity for up to 1.0 hours of participation for continuing education for allied health professionals.
- 1.00 AMA PRA Category 1 Credit(s)™AMA PRA Category 1 Credit(s)™
- 1.00 Hours of ParticipationHours of Participation credit.
The visiting professor series is designed to offer timely, current and critical education to all types of Anesthesia practitioners (faculty, ancillary staff, and residents). The visiting professor series will focus on the integration of new research/literature/techniques into the current knowledge base of the faculty and residents. Much emphasis will be given on how to integrate the information into clinical practices. Speakers are carefully selected based on the quality of the education they will provide the audience (new information/skills/techniques) and the relevance and timeliness to the field of Anesthesiology.
Allied Health Care Professionals
- Acquire new and updated (relevant, evidence - based, and best practices) knowledge
- Be able to apply that knowledge to clinical practice by promoting current anesthetic standards
- Learn new skills and/or information that participants will be able to integrate into clinical work that may increase quality of care, patient safety, and cost effectiveness
- Learn how to more effectively develop (acquire/integrate) effective clinical care plans
Presenter: Chad Brummett, MD
In accordance with the ACCME® standards for Commercial Support Number 6, all in control of content disclosed any relevant financial relationships. These relationships were reviewed via the MCW conflict of interest resolution process and resolved:
|Chad Brummett||Recro Pharma, Inc.||Consulting/Advisory Board|
|Chad Brummett||MyNIH-DHHS-US-17-PAF02680 (R01 DA042859-05): oPioids: Prevention of latrogenic Opioid Dependence after Surgery;||PI|
|Chad Brummett||NIH-DHHS-US-16-PAF06270 (R01 HD088712-05) Peripheral and Central Nervous System Correlates of Persistent Post-Hysterectomy Pain||CO-PI TipReport|
|Chad Brummett||NIH0DHHS-US-16 PAF 07628 (R01 NR017096-05) Resilience Skills Self- Management for Chronic Pain||CO-PI|
|Chad Brummett||NIH-DHHS-US (K23 DA038718-04) Chronic Pain through Individualized Opioid Cessation||CO-PI|
|Chad Brummett||MDHHS (Sub K Michigan OPEN)||PI|
|Chad Brummett||NIH-DHHS (P50 AR070600-05 CORT)||PI|
|Chad Brummett||NIDA (Centralized Pain Opioid Non-Responsiveness R01 DA038261-05)||PI|
|Chad Brummett||UM Michigan Genomics Initiative||CO-PI|
|Chad Brummett||Peripheral Perineural Dexmedetomidine (no royalties) Application number 12/791,506; Issue Date 4/2/13; Patent Number 8410140||Patent|
|Chad Brummett||Heron Therapeutics||Consulting/Advisory Board|